Drug-labels.com

NTP-Sumatriptan Df: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx) Current status: Cancelled Pre Market
Strength:
25 mg, 50 mg, 100 mg

Patient Medication Information: uses, side effects, how to take - NTP-Sumatriptan Df

ABOUT THIS MEDICATION

The name of your medicine is NTP-SUMATRIPTAN DF (sumatriptan succinate) Tablets. They can be obtained only by prescription from your doctor. The decision to use NTP-SUMATRIPTAN DF Tablets is one that you and your doctor should make jointly, taking into account your individual preferences and medical circumstances. If you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or you are postmenopausal or a male over 40), you should tell your doctor, who should evaluate you for heart disease in order to determine if NTP-SUMATRIPTAN DF Tablets are appropriate for you.

What the medication is used for:

NTP-SUMATRIPTAN DF Tablets are intended to relieve your migraine headache and other associated symptoms of a migraine attack. NTP-SUMATRIPTAN DF Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use NTP-SUMATRIPTAN DF Tablets only to treat an actual migraine headache attack.

What it does:

Migraine headache is believed to be caused by a widening of the blood vessels in the head. NTP-SUMATRIPTAN DF narrows these vessels and relieves the symptoms of migraine headache.

When it should not be used:

Do not use NTP-SUMATRIPTAN DF if :

  • you are allergic to sumatriptan succinate or to any of the ingredients in NTP-SUMATRIPTAN DF (See “What the nonmedicinal ingredients are:”).
  • you have a history, or any symptoms or signs of a heart condition
  • you have high blood pressure
  • you are taking or have recently taken (within 2 weeks) a monoamine oxidase inhibitor (MAOI)
  • you are taking or have recently taken (within 24

    hours) an ergotamine-containing medication or its derivatives, or another triptan used to treat migraine

    • you have any degree of liver disease

NTP-SUMATRIPTAN DF Tablets should not be used for the treatment of other types of headaches that are different from migraine attacks.

What the medicinal ingredient is:

Sumatriptan succinate

What the nonmedicinal ingredients are:

NTP-SUMATRIPTAN DF : colloidal silicon dioxide, lactose, magnesium stearate, microcrystalline cellulose and crospovidone The film-coating for the 25 mg and 50 mg tablets consists of titanium dioxide, polydextrose, hydroxypropyl methylcellulose, triacetin, polyethylene glycol.

The film-coating for the 100 mg tablet consists of titanium dioxide, polydextrose, hydroxypropyl methylcellulose, triacetin, polyethylene glycol, synthetic red iron oxide.

What dosage forms it comes in:

NTP-SUMATRIPTAN DF is available as pink 100 mg, white 50 mg, or white 25 mg film-coated tablets in bottles of 50 and blister packs of 6, 24 & 100 Tablets.

WARNINGS AND PRECAUTIONS

BEFORE you use NTP-SUMATRIPTAN DF talk to your doctor or pharmacist if:

  • you are pregnant, think you might be pregnant, you are trying to become pregnant, you are using inadequate contraception or you are breast-feeding.
  • you have any chest pain, heart disease, shortness of breath, or irregular heartbeats, you have had a heart attack, or you have angina.
  • you have risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease, or are you postmenopausal or a male over 40).
  • you have ever had to stop taking this or any other medication because of an allergy or other problems, or you are allergic to sulpha-containing drugs.
  • you are taking any medications, including migraine medications such as other triptans, 5-HT1 agonists or those containing ergotamine, dihydroergotamine, or methysergide.
  • you have ever experienced difficulty moving one side of your body when you have a headache.
  • you have ever had a stroke, transient ischemic attacks

    (TIAs ), or Raynaud’s Syndrome.

  • you are under 18 years of age
  • you are over 65 years of age.
  • you are taking any medication for depression (lithium,

    monoamine oxidase inhibitors or selective serotonin reuptake inhibitors (SSRIs), or serotonin noradrenaline reuptake inhibitors (SNRIs)

  • you had, or you have any disease of the liver or kidney.
  • you had, or you have epilepsy or seizures.
  • this headache is different from your usual migraine

    attacks.

NTP-SUMATRIPTAN DF Tablets should not be used continuously to prevent or reduce the number of attacks you experience. Use NTP-SUMATRIPTAN DF Tablets only to treat an actual migraine headache attack.

If you use NTP-SUMATRIPTAN DF Tablets too often, it may make your headaches worse. If this happens, your doctor may tell you to stop taking NTP-SUMATRIPTAN DF Tablets.

The Use of NTP-SUMATRIPTAN DF During Pregnancy

Do not use NTP-SUMATRIPTAN DF Tablets if you are pregnant, think you might be pregnant, are trying to become pregnant, or are not using adequate contraception, unless you have discussed this with your doctor.

INTERACTIONS WITH THIS MEDICATION

Do not use NTP-SUMATRIPTAN DF Tablets if you are taking or have recently taken a monoamine oxidase inhibitors (MAOI) in the last 2 weeks, or any migraine medications containing ergotamine, ergot derivatives (such as dihydroergotamine, or methysergide), or other triptans used to treat migraine within 24 hours.

You should tell your doctor if you are taking or have recently taken any other medications (prescription, nonprescription or natural/herbal), before you start taking NTP-SUMATRIPTAN DF Tablets, especially any antidepressants such as selective serotonin reuptake inhibitors (SSRIs) and certain tricyclics.

PROPER USE OF THIS MEDICATION

The label on the container of your medicine or the leaflet inside should tell you how often to take a dose and the amount you should take in each dose. If it does not or you are not sure, ask your doctor or pharmacist. DO NOT take more medicine or take your medicine more often than you are told.

Usual dose:

Adults: Take as directed by your doctor. If the first tablet does not relieve your headache, do not take further doses of sumatriptan for the same attack. You may take pain medication other than ergotamine-containing preparations for further pain relief. NTP-SUMATRIPTAN DF Tablets may be taken for subsequent attacks.

NTP-SUMATRIPTAN DF Tablets can be taken at any time during your migraine headache.

If your symptoms come back, and it has been two hours since your first tablet, you may take a second tablet.

Do not take more than 200 mg in any 24 hour period.

NTP-SUMATRIPTAN DF Tablets may be taken with or without food. The tablet should be swallowed whole with water. It should not be crushed, chewed or split.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

Like all medications, NTP-SUMATRIPTAN DF Tablets can cause some side effects. You may not experience any of them. For most patients these side effects are likely to be minor and temporary. However, some may be serious. Consult your doctor if you experience these or other side effects.

The most commonly reported side effects of NTP-SUMATRIPTAN DF Tablets are:

  • pain, pressure or tightness in any part of the body, including chest and throat
  • sensations of heaviness
  • unusual sensations including numbness, tingling, heat/burning or cold
  • flushing (redness of the face lasting for a short time)
  • feeling sick or vomiting
  • dizziness
  • drowsiness
  • tiredness
  • weakness

As drowsiness may occur as a result of using NTP-SUMATRIPTAN DF Tablets, do not drive or operate machinery until you are sure that you are not drowsy.

Other side effects include:

  • unusually slow or fast heartbeats, a feeling of irregular and/or forceful heartbeats
  • visual disturbances, usually temporary (scotoma, nystagmus, flickering, diplopia).
  • dystonia, (shaking, tremors or uncontrolled movements)
  • loss of normal colouration in the fingers and toes.

Tell your doctor of these symptoms at your next visit. Very rarely,

some people have reported the following more serious side effects. For information on what to do if you experience these side effects, see the table at the end of this section.

  • pain or tightness in the chest or throat
  • loss of vision
  • shortness of breath; wheeziness; chest tightening; swelling of eyelids, face, or lips; or a skin rash, skin lumps
  • a seizure or fit
  • sudden and/or severe abdominal pain
  • persistent purple discolouration of hands or feet

If you feel unwell in any other way or have any symptoms that you do not understand or find distressing, you should contact your doctor immediately.

SERIOUS SIDE EFFECTS, HOW OFTEN THEY HAPPEN AND

WHAT TO DO ABOUT THEM

Symptoms/effect

Talk with your doctor or

pharmacist

Seek

immediate medical

emergency assistance

Only if severeIn all cases
Common

Unusual sensations including numbness, tingling, feeling hot or cold; pain,

heaviness or pressure in any part of the body including chest and throat.

√
Very rareSymptoms of a heart attack [ chest pain, sweating, shortness of breath]√
Very rareUnusually slow or fast heartbeats, or a feeling of irregular and/or forceful heartbeats√
Very rare

Allergic reactions

[shortness of breath, sudden wheeziness, chest tightness, swelling of the eyelids, face or lips, lumpy skin rash or hives]

√
Very rareSeizures [ loss of consciousness with uncontrollable shaking(“fit”)]√
Very rareLower abdominal pain and/or severe rectal bleeding.√
Very rare

Raynaud’s phenomenon [persistent purple

discolouration of hands or feet]

√
Very rareLoss of vision√

This is not a complete list of side effects. For any unexpected effects while taking NTP-SUMATRIPTAN DF, contact your doctor or pharmacist.

HOW TO STORE IT

Keep your medicine in a safe place where children cannot reach it. It may be harmful to children.

Keep your tablets in a cool, dry place (15°C to 30°C).

If your medication has expired (the expiration date is printed on the treatment pack), throw it away as instructed.

If your doctor decides to stop your treatment, do not keep any leftover medicine unless your doctor tells you to. Throw away your medicine as instructed.

Reminder:

REMEMBER: This medicine is for you. Only a doctor can prescribe it for you. Never give it to someone else. It may harm them even if their symptoms appear to be similar to yours.

Reporting Side Effects

You can help improve the safe use of health

products for Canadians by reporting serious and unexpected side effects to Health Canada. Your report may help to identify new side effects and change the product safety information:

3 ways to report:

  • On online at Medeffect
  • By calling at 1-866-234-2345 (toll-free)
  • By completing a Consumer Side Effect Reporting

    Form and sending it by :

    • Fax to 1-866-678-6789 (toll-free), or
    • Mail to: Canada Vigilance Program Health Canada

      Postal Locator 0701E

      Ottawa, ON K1A 0K9

Postage paid labels, Consumer Side Effect Reporting Form and the adverse reaction reporting guidelines are available on the MedEffect™ Canada Web site at MedEffect.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

This document plus the full product monograph, prepared for health professionals can be found by contacting : Teva Canada Limited at:

1-800-268-4127 ext. 1255005 (English);

1-877-777-9117 (French)

or druginfo@tevacanada.com

Toronto, Ontario

Canada, M1B 2K9

Last revised: September 9, 2015

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02358719

Revision date stated in the text: September 9, 2015

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for NTP-Sumatriptan Df

Rx or OTC
Prescription (Rx)?
DIN 02358719, 02358727, 02358735
Schedule(s) PRESCRIPTION
Active ingredient(s) Sumatriptan (sumatriptan succinate)
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. N Nervous system drugs
    1. N02 Analgesics
      1. N02C Antimigraine preparations
        1. N02CC Selective serotonin (5HT1) agonists, antimigraine drugs
          1. N02CC01 Sumatriptan
Company TEVA CANADA LIMITED
Current status Cancelled Pre Market
Current status date June 13, 2017
Strengths and forms
DIN Strength Dosage form(s) Current status
02358719 25 MG Tablet Cancelled Pre Market June 13, 2017
02358727 50 MG Tablet Cancelled Pre Market June 13, 2017
02358735 100 MG Tablet Cancelled Pre Market June 13, 2017

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.